Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta

Placenta

Volumn 26, Issue 2-3, 2005, Pages 210-217

  Li, H ^a   Gu, B ^a   Zhang, Y ^a   Lewis, D F ^a   Wang, Y ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; LIPID PEROXIDE; MESSENGER RNA; PLACENTAL GROWTH FACTOR; SUPEROXIDE DISMUTASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CENTRIFUGATION; CONTROLLED STUDY; CORRELATION FUNCTION; DELIVERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; STATISTICAL ANALYSIS; TROPHOBLAST; UPREGULATION;

CELL HYPOXIA; CELLS, CULTURED; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; LIPID PEROXIDES; OXIDATIVE STRESS; PREGNANCY PROTEINS; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TROPHOBLASTS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 13844272191     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2004.05.004     Document Type: Article

References (29)

1. Crocker I.P. Strachan B.K. Lash G.E. Cooper S. Warren A.Y. Baker P.N. Vascular endothelial growth factor but not placental growth factor promotes trophoblast syncytialization in vitro J Soc Gynecol Investig 8 2001 341-346
2. Cross J.C. Werb Z. Fisher S.J. Implantation and the placenta: key pieces of the development puzzle Science 266 1994 1508-1518
3. Nelson D.M. Crouch E.C. Curran E.M. Farmer D.R. Trophoblast interaction with fibrin matrix. Epithelialization of perivillous fibrin deposits as a mechanism for villous repair in the human placenta Am J Pathol 136 1990 855-865
4. Torry D.S. Ahn H. Barnes E.L. Torry R.J. Placenta growth factor: potential role in pregnancy Am J Reprod Immunol 41 1999 79-85
5. Maynard S.E. Min J.Y. Merchan J. Lim K.H. Li J. Mondal S. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649-658
6. Sugimoto H. Hamano Y. Charytan D. Cosgrove D. Kieran M. Sudhakar A. et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria J Biol Chem 278 2003 12605-12608
7. Genbacev O. Joslin R. Damsky C.H. Polliotti B.M. Fisher S.J. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia J Clin Invest 97 1996 540-550
8. Kingdom J.C.P. Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia Placenta 18 1997 613-621
9. Ahmed A. Dunk C. Ahmed S. Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) and soluble Flt-1 by oxygen - a review Placenta 21 2000 S16-S24
10. Cooper J.C. Sharkey A.M. Charnock-Jones D.S. Palmer C.R. Smith S.K. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia Br J Obstet Gynaecol 103 1996 1191-1196
11. Khaliq A. Dunk C. Jiang J. Shams M. Li X.F. Acevedo C. et al. Hypoxia down regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction Lab Invest 2 1999 151-170
12. Desai J. Holt-Shore V. Torry R.J. Caudle M.R. Torry D.S. Signal transduction and biological function of placenta growth factor in primary human trophoblast Biol Reprod 60 1999 887-892
13. Shore V.H. Wang T.-H. Wang C.-L. Torry R.J. Caudle M.R. Torry D.S. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast Placenta 18 1997 657-665
14. Koga K. Osuga Y. Yoshino O. Hirota Y. Ruimeng X. Hirata T. et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia J Clin Endocrinol Metab 88 2003 2348-2351
15. Khaliq A. Li X.F. Shams M. Sisi P. Acevedo C.A. Whittle M.J. et al. Localisation of placenta growth factor (PIGF) in human term placenta Growth Factors 13 1996 243-250
16. Regnault T.R.H. Orbus R.J. de Vrijer B. Davidsen M.L. Galan H.L. Wilkening R.B. et al. Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR) Placenta 23 2002 132-144
17. Wang Y. Walsh S.W. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in preeclampsia Placenta 22 2001 206-212
18. Jentzsch A.M. Bachmann H. Furst P. Biesalski H.K. Improved analysis of malondialdehyde in human body fluids Free Radic Biol Med 20 1996 251-256
19. Walsh S.W. Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia J Clin Endocrinol Metab 80 1995 1888-1893
20. Clark D.E. Smith S.K. He Y. Day K.A. Licence D.R. Corps A.N. et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation Biol Reprod 59 1998 1540-1548
21. Ahmed A. Kilby M.D. Hypoxia or hyperoxia in placental insufficiency? Lancet 350 9081 1997 826-827
22. Gerber H.P. Condorelli F. Park J. Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia J Biol Chem 272 38 1997 23659-23667
23. Rajakumar A. Doty K. Daftary A. Harger G. Conrad K.P. Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae Placenta 2-3 2003 199-208
24. De Marco C.S. Caniggia I. Mechanisms of oxygen sensing in human trophoblast cells Placenta 23 Suppl A 2002 S58-S68
25. Torry D.S. Wang H.S. Wang T.H. Caudle M.R. Torry R.J. Preeclampsia is associated with reduced serum levels of placenta growth factor Am J Obstet Gynecol 179 1998 1539-1544
26. Taylor R.N. Grimwood J. Taylor R.S. McMaster M.T. Fisher S.J. North R.A. Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies Am J Obstet Gynecol 188 2003 177-182
27. Baker P.N. Krasnow J. Roberts J.M. Yeo K.T. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia Obstet Gynecol 86 1995 815-821
28. Brockelsby J.C. Wheeler T. Anthony F.W. Wellings R. Baker P.N. Increased circulating levels of vascular endothelial growth factor in preeclampsia Hypertens Pregn 17 1998 283-290
29. Levine R.J. Maynard S.E. Qian C. Lim K.H. England L.J. Yu K.F. et al. Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 7 2004 672-683